You may know I’m a blogger at the Biotechnology Industry Organization convention in Atlanta. I’m here and adjusting to the time change. I’m eager to cover stories about San Diego Biotech–we’ve got a lot going on here! Today Paul Grayson, CEO of Fate Therapeutics, and Ian Ratcliffe, CEO of Stemgent, will be speaking in the ‘Mastering Your (Cell) Fate: Stem Cells, iPSCs and the Future of Medicine’ session.’ Check out the BIO blog for the latest. I hope to speak with them, stay tuned! It’s raining off and on here, but I always forget how nice it is to see lots of trees.
SDBN Blog
BIO 2009: Stem Cell Companies’ ‘Fate’ Relies on Interdisciplinary Business Models
I attended the ‘Mastering Your (Cell) Fate: Stem Cells, iPSCs and the Future of Medicine’ session at BIO on Monday, which featured a panel of specialists: G. Steven Burrill, CEO, Burrill & Company, Aaron Rowe, […]
SDBN Blog
BIO 2009: Stem Cell Companies’ ‘Fate’ Relies on Interdisciplinary Business Models
I attended the ‘Mastering Your (Cell) Fate: Stem Cells, iPSCs and the Future of Medicine’ session at BIO on Monday, which featured a panel of specialists: G. Steven Burrill, CEO, Burrill & Company, Aaron Rowe, […]
Headline
SDBN’s June 24th 2014 Downtown Event: Reinventing California Biotech: DIY is the New Bootstrap Event
The California biotech landscape has changed over the past 10 years due to stagnant or decreasing funding for research in both the academic and private sector. However, a new breed of biotechnology champions have taken […]
